Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv Antibody [4A6] Cat. No.: 93-301

Availability: In stock

$0.00

 Price Options

$0.00
psi-iconSpecifications
SPECIES REACTIVITY: Virus
TESTED APPLICATIONS: ELISA
APPLICATIONS: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
SPECIFICITY: Antibody recognizes 2019-nCoV Nucleocapsid Protein

psi-iconProperties
PURIFICATION:≥95 %
CLONALITY:Monoclonal
CONJUGATE:Unconjugated
PHYSICAL STATE:Liquid
BUFFER:20mM PB, 150mM NaCl, pH 7.4.
CONCENTRATION:5.0 mg/ml (+/- 10 %)
STORAGE CONDITIONS:24 months from manufacturing at <-20 ˚C; 1 month, 2 to 8 ˚C under sterile conditions.

psi-iconAdditional Info
OFFICIAL SYMBOL:N
ALTERNATE NAMES:SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Nucleocapsid protein, N protein, Nucleocapsid Phosphoprotein
ACCESSION NO.:QHD43423
PROTEIN GI NO.:1820552696
GENE ID:43740575
USER NOTE:Optimal dilutions for each application to be determined by the researcher.
psi-iconBackground and References
BACKGROUND:Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.